Array Biopharma
Array Biopharma’s Braftovi triple therapy meets both endpoints in advanced colorectal cancer subtype
May 22, 2019Research and Development Array Biopharma, Braftovi, Cancer, colorectal cancer, pharma
Array Biopharma has revealed new data on its combination of Braftovi (encorafenib), Mektovi (binimetinib), and Erbitux (cetuximab), showing that it …
Array’s melanoma therapy blasts Roche’s out of water
February 7, 2018Research and Development Array Biopharma, Pierre Fabre, Roche, biotech, drugs, melanoma, pharma, pharmaceutical
Array Biopharma suffered a serious knock back in early 2017 when its plan to commercialise its drug, binimetinib, were derailed …
Array BioPharma demands $192m after AstraZeneca refuses to pay royalties
February 2, 2018Medical Communications, Sales and Marketing Array Biopharma, AstraZeneca, lawsuit, selemetinib
Array BioPharma has launched a lawsuit against AstraZeneca over allegations the latter has refused to pay royalties it owes for …
BMS and Array BioPharma partner up to tackle colorectal cancer
May 30, 2017Manufacturing and Production, Research and Development, Sales and Marketing Array Biopharma, BMS, Bristol-Myers Squibb
Bristol-Myers Squibb and Array BioPharma have announced they are to join forces as part of a new clinical research partnership …
Array BioPharma in disarray over withdrawal of NDA
March 20, 2017Manufacturing and Production, Sales and Marketing Array Biopharma
Array BioPharma has announced that it has pulled its new drug application (NDA) for its drug, binimetinib, for the treatment …
